Nabla’s JAM is a multimodal generative modeling system trained on protein sequence and structure data and Nabla-generated human-relevant measurements. It supports biologics design, epitope work, optimization, and multispecific architecture generation.
The company says it invests in its platform and maintains high scientific standards to advance drug design. Its work focuses on technology development, rapid learning, and designing molecules that may reach patients.
The company’s scientists and engineers aim to make drug development a design discipline. Its culture emphasizes data-driven debate, growth, and daily in-person lab work.
Welcome to the website of Nabla Bio. This website is designed and intended to provide information to visitors about Nabla Bio. This Privacy Policy describes Nabla Bio’s policy regarding information that it receives or collects from visitors to the website.